Skip to content

The Effect of a Home-Based, Online, Personalized, Dynamic Multidomain Intervention on Cognitive Function in Patients with Cardiometabolic Multimorbidity and Their Caregivers: The 'LifeWise' Randomized Controlled Trial.

The Effect of a Home-Based, Online, Personalized, Dynamic Multidomain Intervention on Cognitive Function in Patients with Cardiometabolic Multimorbidity and Their Caregivers: The 'LifeWise' Randomized Controlled Trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500098252
Enrollment
Unknown
Registered
2025-03-05
Start date
2025-03-06
Completion date
Unknown
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiometabolic multimorbidity

Interventions

Cardiovascular metabolic comorbidity binary intervention group:The 'LifeWise' program
Cardiovascular metabolic comorbidity binary control group:Routine follow-up management

Sponsors

Tianjin Medical University General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 85 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria of patients are: a. co-existing cardiovascular disease (either hypertension, coronary heart disease, or stroke) and diabetes; c. Age >=65 years old; d. The patient knows the stage of the disease; e. Have complete language expression ability; d. Proficient in reading and writing with smart phones. The inclusion criteria of family caregivers are: a. family members or close relatives of patients, who bear the primary responsibility for caring for patients; b. Weekly care duration >=24h; b. Have complete language expression ability; c. Be able to read and write using smart phones.

Exclusion criteria

Exclusion criteria: Exclusion criteria for patients were as follows : a had been diagnosed with dementia or had a score of < 24 on the MMSE; .b. Serious physical or psychological harm or illness, e.g., cancer, severe liver or kidney dysfunction, patients with grade IV heart failure, schizophrenia; c. severe loss of vision, hearing, or communication ability; d. Have participated in any other clinical trials within the past 6 months. Exclusion criteria for family caregivers were as follows :a had been diagnosed with dementia or had a score of < 24 on the MMSE; b. Serious physical or psychological harm or illness, e.g., cancer, severe liver or kidney dysfunction, patients with grade IV heart failure, schizophrenia; c. severe loss of vision, hearing, or communication d. participation in an intervention other than usual care within the last 6 months;

Design outcomes

Primary

MeasureTime frame
Cognitive function for patients;

Secondary

MeasureTime frame
Cognitive function for caregivers;self-care for patients;caregiver contribution to patient self-care;Glycated hemoglobin (HbA1c) and fasting blood glucose (FPG) for patients;Systolic and diastolic Blood pressure (SBP/DBP) for patients;Lipid profile;BMI for patients;Depression for patients;Depression for caregivers;Social isolation for patients;healthy sleep index for patients;healthy sleep index for caregivers;All-cause readmission for patients;All-cause mortality for patients;AVLT-H for patients;AFT for patients;DSST for patients;AVLT-H for caregivers;AFT for caregivers;DSST for caregivers;Incident dementia for patients;Physical activity for patients;Physical activity for caregivers;

Countries

China

Contacts

Public ContactGao Ying/ Yang Weiling

Tianjin Medical University General Hospital/ Tianjin Medical University

winglingy@163.com+86 188 2279 2615

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026